|IN THIS ISSUE|
On the fence regarding advertising? Don’t wait. Use the HealthEconomics.com Partnership program to reach over 21,000 HEOR professionals around the world. Cost-effective options for every budget. Contact Us.
|SPOTLIGHT 1 OF THE WEEK||SPOTLIGHT 2 OF THE WEEK|
How Can You Design More Effective Phase IV Studies?
U.S. Spent $124 Billion for Specialty Meds in 2014.
ISPOR Announces New Student Member Benefit.
U.S. Senate Passes Symbolic ObamaCare Repeal.
Who Will be Testifying at the Congressional Hearing on Pharmaceutical Pricing?
Don’t Miss Deadline-Part 1 of AFPE Pre-Doctoral Application.
ICER Releases Final Report on Congestive Heart Failure Management.
Shkreli Says He Didn’t Go Far Enough with Daraprim Price Hike.
|Link of the Week||Conference of the Week||Webinar of the Week|